FGF21 and obesity due to melanocortin 4 receptor deficiency: Considering the fact that obesity, metabolic disorders, and estrogen imbalance are important factors in the pathogenesis of both breast and endometrial cancer, the potential involvement of FGF21 is also pointed out in endometrial cancer patients [15].